These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 21183355)

  • 21. Monoamine oxidase inhibition by selected anilide derivatives.
    Legoabe L; Kruger J; Petzer A; Bergh JJ; Petzer JP
    Eur J Med Chem; 2011 Oct; 46(10):5162-74. PubMed ID: 21899930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Docking studies on monoamine oxidase-B inhibitors: estimation of inhibition constants (K(i)) of a series of experimentally tested compounds.
    Toprakçí M; Yelekçi K
    Bioorg Med Chem Lett; 2005 Oct; 15(20):4438-46. PubMed ID: 16137882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of monoamine oxidase A by beta-carboline derivatives.
    Kim H; Sablin SO; Ramsay RR
    Arch Biochem Biophys; 1997 Jan; 337(1):137-42. PubMed ID: 8990278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 8-Aryl- and alkyloxycaffeine analogues as inhibitors of monoamine oxidase.
    Strydom B; Bergh JJ; Petzer JP
    Eur J Med Chem; 2011 Aug; 46(8):3474-85. PubMed ID: 21621312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and selective inhibitory activity of 1-acetyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives against monoamine oxidase.
    Chimenti F; Bolasco A; Manna F; Secci D; Chimenti P; Befani O; Turini P; Giovannini V; Mondovì B; Cirilli R; La Torre F
    J Med Chem; 2004 Apr; 47(8):2071-4. PubMed ID: 15056004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis, molecular modeling studies, and selective inhibitory activity against monoamine oxidase of 1-thiocarbamoyl-3,5-diaryl-4,5-dihydro-(1H)- pyrazole derivatives.
    Chimenti F; Maccioni E; Secci D; Bolasco A; Chimenti P; Granese A; Befani O; Turini P; Alcaro S; Ortuso F; Cirilli R; La Torre F; Cardia MC; Distinto S
    J Med Chem; 2005 Nov; 48(23):7113-22. PubMed ID: 16279769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New pyrazoline bearing 4(3H)-quinazolinone inhibitors of monoamine oxidase: synthesis, biological evaluation, and structural determinants of MAO-A and MAO-B selectivity.
    Gökhan-Kelekçi N; Koyunoğlu S; Yabanoğlu S; Yelekçi K; Ozgen O; Uçar G; Erol K; Kendi E; Yeşilada A
    Bioorg Med Chem; 2009 Jan; 17(2):675-89. PubMed ID: 19091581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of monoamine oxidase (MAO) by β-carbolines and their interactions in live neuronal (PC12) and liver (HuH-7 and MH1C1) cells.
    Santillo MF; Liu Y; Ferguson M; Vohra SN; Wiesenfeld PL
    Toxicol In Vitro; 2014 Apr; 28(3):403-10. PubMed ID: 24373881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 1,3,4-Oxadiazole-3(2H)-carboxamide derivatives as potential novel class of monoamine oxidase (MAO) inhibitors: synthesis, evaluation, and role of urea moiety.
    Ke S; Li Z; Qian X
    Bioorg Med Chem; 2008 Aug; 16(16):7565-72. PubMed ID: 18678501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective inhibition of monoamine oxidase B by aminoethyl substituted benzyl ethers.
    Woodroofe CC; Mostashari R; Lu X; Ramsay RR; Silverman RB
    J Enzyme Inhib; 2000; 15(1):11-21. PubMed ID: 10850952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 2-Arylthiomorpholine derivatives as potent and selective monoamine oxidase B inhibitors.
    Lühr S; Vilches-Herrera M; Fierro A; Ramsay RR; Edmondson DE; Reyes-Parada M; Cassels BK; Iturriaga-Vásquez P
    Bioorg Med Chem; 2010 Feb; 18(4):1388-95. PubMed ID: 20123154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of a novel class of potent coumarin monoamine oxidase B inhibitors: development and biopharmacological profiling of 7-[(3-chlorobenzyl)oxy]-4-[(methylamino)methyl]-2H-chromen-2-one methanesulfonate (NW-1772) as a highly potent, selective, reversible, and orally active monoamine oxidase B inhibitor.
    Pisani L; Muncipinto G; Miscioscia TF; Nicolotti O; Leonetti F; Catto M; Caccia C; Salvati P; Soto-Otero R; Mendez-Alvarez E; Passeleu C; Carotti A
    J Med Chem; 2009 Nov; 52(21):6685-706. PubMed ID: 19810674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of selective and reversible pyrazoline based MAO-A inhibitors: Synthesis, biological evaluation and docking studies.
    Karuppasamy M; Mahapatra M; Yabanoglu S; Ucar G; Sinha BN; Basu A; Mishra N; Sharon A; Kulandaivelu U; Jayaprakash V
    Bioorg Med Chem; 2010 Mar; 18(5):1875-81. PubMed ID: 20149663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design, synthesis, in vitro MAO-B inhibitory evaluation, and computational studies of some 6-nitrobenzothiazole-derived semicarbazones.
    Tripathi RK; Goshain O; Ayyannan SR
    ChemMedChem; 2013 Mar; 8(3):462-74. PubMed ID: 23325700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and study of a series of 3-arylcoumarins as potent and selective monoamine oxidase B inhibitors.
    Matos MJ; Terán C; Pérez-Castillo Y; Uriarte E; Santana L; Viña D
    J Med Chem; 2011 Oct; 54(20):7127-37. PubMed ID: 21923181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis, structure-activity relationships and molecular modeling studies of new indole inhibitors of monoamine oxidases A and B.
    La Regina G; Silvestri R; Gatti V; Lavecchia A; Novellino E; Befani O; Turini P; Agostinelli E
    Bioorg Med Chem; 2008 Nov; 16(22):9729-40. PubMed ID: 18951803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of monoamine oxidase by C5-substituted phthalimide analogues.
    Manley-King CI; Bergh JJ; Petzer JP
    Bioorg Med Chem; 2011 Aug; 19(16):4829-40. PubMed ID: 21778064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-affinity binding of beta-carbolines to imidazoline I2B receptors and MAO-A in rat tissues: norharman blocks the effect of morphine withdrawal on DOPA/noradrenaline synthesis in the brain.
    Miralles A; Esteban S; Sastre-Coll A; Moranta D; Asensio VJ; García-Sevilla JA
    Eur J Pharmacol; 2005 Aug; 518(2-3):234-42. PubMed ID: 16061219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of species-dependent differences on screening, design, and development of MAO B inhibitors.
    Novaroli L; Daina A; Favre E; Bravo J; Carotti A; Leonetti F; Catto M; Carrupt PA; Reist M
    J Med Chem; 2006 Oct; 49(21):6264-72. PubMed ID: 17034132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis, molecular modeling studies and selective inhibitory activity against MAO of N1-propanoyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives.
    Chimenti F; Fioravanti R; Bolasco A; Manna F; Chimenti P; Secci D; Rossi F; Turini P; Ortuso F; Alcaro S; Cardia MC
    Eur J Med Chem; 2008 Oct; 43(10):2262-7. PubMed ID: 18281126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.